XE
X-Energy-A (XE)
NASDAQ
$21.40+$1.24 (+6.16%)
Price as of Jun 23, 2026 1:54 PM EDT
  • $5.8B
    Market Cap
  • 107.05%
    1-Year Change
  • Specialty Industrial Machinery
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: N/A
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

X-energy Reports First Quarter 2026 Results

X-Energy announced Q1 2026 financial results with revenues of $43 million (109% increase YoY) following its April 2026 IPO that raised $1.1 billion in net proceeds. The company achieved significant regulatory milestones including NRC environmental clearance for Dow's Seadrift advanced nuclear project and a Part 70 fuel fabrication license for TRISO-X fuel. X-Energy also submitted its Xe-100 reactor for UK Generic Design Assessment and signed strategic partnerships with SGL Carbon and IHI Corporation for supply chain support.

06/04/2026, 6:00 AMGlobeNewswire

Earnings Volatility Watch: 10 Stocks Set For Big Moves This Week, From Nuclear Power To Whiskey Maker

Options markets are pricing significant implied moves between 15.92% and 21.71% across 10 stocks reporting this week, spanning AI infrastructure suppliers, nuclear power, cybersecurity, and consumer staples. The largest moves are expected for Netskope (21.71%), Brown-Forman (20.51%), and Planet Labs (18.95%), with major mega-cap companies like Broadcom, CrowdStrike, and Palo Alto Networks also reporting amid continued AI infrastructure demand.

06/01/2026, 3:15 PMBenzinga

Global Nuclear Small Modular Reactors (SMRs) Research Report 2026-2046, 60+ Detailed Company Profiles Covering Technology, Funding, Pipeline, Partnerships and Contacts

The global SMR market is entering a 'Golden Age of Nuclear' with 2025-2026 marking a pivotal inflection point. With a market potential of $0.5-1.5 trillion and a 700 GW transformation scenario by 2050, governments and hyperscalers are converging on SMRs as scalable zero-carbon power sources. Recent funding includes UK's £599 million to Rolls-Royce SMR, US DOE's $800 million to TVA/Holtec, and landmark offtake deals from Amazon, Google, and Equinix. Cost targets aim to decline from ~$125/MWh to $40-70/MWh through manufacturing innovation.

05/20/2026, 5:55 AMGlobeNewswire

Should You Invest in This Artificial Intelligence (AI) IPO Stock That Has a Partnership with Amazon?

X-Energy, a small modular nuclear reactor developer backed by Amazon, went public in April 2026 at $23 per share and is now trading at $31.80. While the company has secured major partnerships including a 5 GW deal with Amazon by 2039, it remains unprofitable with a $390 million comprehensive loss in 2025 and won't produce commercial products until around 2030. The analyst recommends investors consider Amazon or established clean-energy companies instead due to X-Energy's high uncertainty and competition from rivals like Oklo and NuScale.

05/07/2026, 2:05 AMThe Motley Fool

HawkEye Set For NYSE Debut After Raising $416 Million, IPO Priced At $26

HawkEye 360, a space analytics company, priced its IPO at $26 per share and raised $416 million through the sale of 16 million shares. The Herndon, Virginia-based company is set to debut on the NYSE under ticker 'HAWK' on Thursday. The IPO reflects growing investor demand for space intelligence and signals recovery in the U.S. IPO market.

05/07/2026, 12:16 AMBenzinga

1 Update Amazon CEO Andy Jassy Just Said That Every Artificial Intelligence (AI) Investor Should Hear

Amazon reported strong Q1 results with 17% sales growth and 30% operating income increase. AWS accelerated growth to 28% YoY, driven by AI demand. CEO Jassy emphasized the company's $200 billion 2026 capex investment in infrastructure (land, power, buildings, chips, servers) is essential for AI expansion, typically monetized 6-24 months after spending. The article highlights investment opportunities in AI supply chain companies providing critical components to hyperscalers.

05/05/2026, 12:05 PMThe Motley Fool

Seaport Therapeutics Set For Nasdaq Debut After Raising $255 Million In IPO

Seaport Therapeutics, a clinical-stage biotech firm focused on neuropsychiatric treatments, priced its IPO at $18 per share, raising approximately $255 million. The Boston-based company will begin trading on Nasdaq under ticker SPTX on Friday. The IPO reflects growing market activity in the biotech sector, with recent successful debuts from X-Energy and Aevex Corp.

05/01/2026, 6:28 AMBenzinga

Peers

Statistics

More
Day Range
$19.90
$21.34
$20.16
1-Year Range
$18.02
$35.98
$20.16
Latest Close$20.16
Change
-$1.40 (-6.97%)
Volume2,917,406
Market Cap$5.8B
Shares Outstanding287.5M
Enterprise Value$5.6B

Information as of 06/22/2026

Company Profile

$5.8B
Market Cap
-$166.2M
Net Income
Sector: Industrials
Industry: Specialty Industrial Machinery
530 Gaither Road, Rockville, MD, United States, 20850
(301) 358-5600

X-Energy, Inc. designs and develops nuclear reactor technology. The company manufactures nuclear fuels. It provides the Xe-100 reactor that is designed to generate 80 megawatts of electric power or 200 megawatts of thermal output (heat) and TRISO-X, a fuel for reactors. The company was founded in 2009 and is headquartered in Rockville, Maryland.

Key Executives

  • J. Clay Sell
  • Dragan Popovic
  • Kamal Ghaffarian
  • Daniel Andrew Gross
  • Laura Garcia

Current Ownership Distribution

  • Insiders73.2M (100.00%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)
  • Other0 (0.00%)